Background: The conventional method for testing Hepatitis B (HBsAg) can be not detected occult Hepatitis B in patients. No diagnosis of hepatitis B in patients with lupus nephritis and glomerulopathy treated with Immunosuppressive drugs, can be clear Hepatitis B. Also, due to the possible role of occult Hepatitis B in the lack of a complete response to treatment and continue proteinuria Assess the prevalence of occult Hepatitis B in these patients is important.in this study we decided to the survey Prevalence of occult hepatitis B in patients with lupus nephritis and glomerulopathy referred to SHAHID SADOUGHI Hospital in Yazd.Methods: This study was a descriptive-cross sectional study. A total of 112 patients with lupus nephritis and glomerulopathy referred to internal department, nephrology and rheumatology clinic of SHAHID SADOUGHI Hospital in five-year period studied. HBsAg, HBsAb was measured in patients and those with HBsAg positive and HBsAg negative HBV-DNA was measured. Demographic was collected in the questionnaire that already provided. The collected data were entered into SPSS version 20, using statistical tests were analyzed.Result: The results showed that the mean age of participants was 40.84 ± 15.11 years. From 112 patients participated in the study,49 patients (43.8%) were men and63 patients (56.2%) were female. Also from 112 patients,97 patients (86.6%) had primary glomerulopathy and 15 patients (13.4%) had lupus nephritis. The prevalence of occult hepatitis B was 3.0% in patients with primary glomerulopathy and 13.3% in lupus nephritis patients. There was a significant relationship between the frequency of HBc-Ab and the mean age of patients with type of disease (P-value <0.05).Conclusion: The prevalence of occult hepatitis B in patients with lupus nephritis was greater than the prevalence in pateints with gleumeronephritis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.